HC Wainwright initiated coverage on Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), a commercial-stage biopharmaceutical firm primarily focusing on neurological and neuropsychiatry disorders.

HC Wainwright sets an $18 target on Vanda Pharmaceuticals amid a 30% discount to cash reserves. Vanda's portfolio could reach key clinical and regulatory milestones within 6–18 months.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Doctors and parents are warning about a rise in walking pneumonia among US children - a year after a frightening outbreak overseas. The infection, also known as 'white lung' pneumonia, is caused ...

Roxas District in Quezon City turned into a river following the non-stop rains, which prompted the evacuation of residents along Gumamela and Waling-Waling Streets. But residents like Neil Nicart, who ...

The Quezon City government has posted a list of the status of roads amid the heavy rains brought about by Severe Tropical Storm Kristine. "Patuloy ang pagsisikap ng ating lokal na pamahalaan na ...

Oct 14 (Reuters) - Vanda Pharmaceuticals (VNDA.O), opens new tab on Monday rejected UK-based Cycle Pharmaceuticals' second takeover proposal, which values the drugmaker at $8 per share despite a ...

In the 1980s and the 1990s, she was known as the woman who pioneered the propagation of the orchid “waling-waling” (Vanda sanderiana), which used to thrive only in the forests of Mt. Apo. Her ...

Here, we’ll take you through 10 of the most popular types of Vanda orchids to grow at home including their origins, history, and botanical characteristics. The waling-waling orchid grows natively on ...